Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$0.65
Change (%) Stock is Down 0.01 (1.52%)
Volume62,211
Data as of 07/22/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
07/21/14Bacterin Announces Preliminary Second Quarter 2014 Results
Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year. BELGRADE, Mont., July 21, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary unaudited results for the second quarter of 2014. The Company is anticipating total net revenu... 
Printer Friendly Version
07/01/14Bacterin Announces the Appointment of Robert Di Silvio as President
BELGRADE, Mont., July 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Robert (Bob) Di Silvio as President of the Company. Mr. Di Silvio brings over 30 years' experience serving in executive management positions in the medical industry, overseeing sales and marketing efforts in the management of medical sales operations. ... 
Printer Friendly Version
06/10/14Bacterin to Present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference
BELGRADE, Mont., June 10, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference, to be held June 13, 2014 at the W New York Hotel. Bacterin's presentation will take place Friday, June 13, 2014 at 11 AM EST. A live broadcast of the ... 
Printer Friendly Version
05/06/14Bacterin Announces First Quarter 2014 Results
Company reports record core recurring biologics revenues of $8.7 million BELGRADE, Mont.--(BUSINESS WIRE)--May 6, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today reported financial results for the first quarter ended March 31, 2014. The Company reported quarterly revenues just over $8.9 million, and a net loss for the qu... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.